Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
January 08, 2025 08:30 ET
|
OncoCyte Corporation
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
January 06, 2025 16:05 ET
|
OncoCyte Corporation
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings
December 09, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings – January 13-16, 2025, San Francisco, CA
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
December 04, 2024 16:15 ET
|
OncoCyte Corporation
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
November 12, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
November 06, 2024 16:45 ET
|
OncoCyte Corporation
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
October 16, 2024 16:15 ET
|
OncoCyte Corporation
Oncocyte Announces Participation in the LD Micro Main Event XVII
Conference in Los Angeles
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
August 12, 2024 16:10 ET
|
OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
August 08, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results
Oncocyte Announces August Investor Conferences Participation
August 05, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Announces August Investor Conferences Participation